Search results
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 2 days agoOther vaccine stocks are climbing as well. Shares of CureVac which, like Moderna, develops messenger...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks· 2 days agoFree Report) and Pfizer (PFE Quick QuotePFE - Free Report) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known as bird flu, in ...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 1 day agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 5 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
Free COVID-19 vaccines could be a thing of the past as federal program is set to expire early
Chicago Sun-Times· 2 days agoWhen COVID-19 vaccines entered the commercial market, the federal government introduced a program to...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 2 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 1 day agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 2 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...